YARDLEY, Pa., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the ...
Optinose named Terry Kohler as its chief financial officer. Kohler is an experienced biotech finance leader, having worked over 20 years in the industry, the Yardley, Pa., pharmaceutical company said ...